Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hao Hu, Kun Qian, Meng-Chiao Ho & Y. George Zheng. (2016) Small Molecule Inhibitors of Protein Arginine Methyltransferases. Expert Opinion on Investigational Drugs 25:3, pages 335-358.
Read now
Read now
Articles from other publishers (34)
Yan-Ruide Li, Ying Fang, Zibai Lyu, Yichen Zhu & Lili Yang. (2023) Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. Journal of Translational Medicine 21:1.
Crossref
Crossref
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi & Sorayya Ghasemi. (2023) Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. Pathology - Research and Practice 248, pages 154688.
Crossref
Crossref
Xincheng Liu, Cui Guo, Tiandong Leng, Zhen Fan, Jialuo Mai, Jiehong Chen, Jinhai Xu, Qianyi Li, Bin Jiang, Ke Sai, Wenzhuo Yang, Jiayu Gu, Jingyi Wang, Shuxin Sun, Zhijie Chen, Yingqian Zhong, Xuanming Liang, Chaoxin Chen, Jing Cai, Yuan Lin, Jiankai Liang, Jun Hu, Guangmei Yan, Wenbo Zhu & Wei Yin. (2023) Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell. Cell Death & Disease 14:2.
Crossref
Crossref
Chen Chen, Zehua Wang & Yanru Qin. (2022) Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy. Frontiers in Pharmacology 13.
Crossref
Crossref
Qi Zhang & Wei Li. (2022) Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy. World Journal of Stem Cells 14:4, pages 267-286.
Crossref
Crossref
Saeedeh Keyvani-Ghamsari, Khatereh Khorsandi, Azhar Rasul & Muhammad Khatir Zaman. (2021) Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clinical Epigenetics 13:1.
Crossref
Crossref
Elham Barazeghi, Per Hellman, Olov Norlén, Gunnar Westin & Peter Stålberg. (2021) EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine. Scientific Reports 11:1.
Crossref
Crossref
Daniel Desaulniers, Paule Vasseur, Abigail Jacobs, M. Cecilia Aguila, Norman Ertych & Miriam N. Jacobs. (2021) Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications. International Journal of Molecular Sciences 22:20, pages 10969.
Crossref
Crossref
Gera Narendra, Baddipadige Raju, Himanshu Verma & Om Silakari. (2021) Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis. Medical Oncology 38:10.
Crossref
Crossref
Yang Yang, Dan Xing, Yawei Wang, Haobo Jia, Bing Li & Jiao Jiao Li. (2020) A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway. BMC Molecular and Cell Biology 21:1.
Crossref
Crossref
Gabriell Bonifacio Borgato, Gabriel Alvares Borges, Ana Paula Souza, Cristiane Helena Squarize & Rogerio Moraes Castilho. (2020) Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 130:2, pages 181-190.
Crossref
Crossref
Lucia Cabal-Hierro, Peter van Galen, Miguel A. Prado, Kelly J. Higby, Katsuhiro Togami, Cody T. Mowery, Joao A. Paulo, Yingtian Xie, Paloma Cejas, Takashi Furusawa, Michael Bustin, Henry W. Long, David B. Sykes, Steven P. Gygi, Daniel Finley, Bradley E. Bernstein & Andrew A. Lane. (2020) Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. Nature Communications 11:1.
Crossref
Crossref
M. Perusina Lanfranca, J.K. Thompson, F. Bednar, C. Halbrook, C. Lyssiotis, B. Levi & T.L. Frankel. (2019) Metabolism and epigenetics of pancreatic cancer stem cells. Seminars in Cancer Biology 57, pages 19-26.
Crossref
Crossref
Fabiana Crispo, Valentina Condelli, Silvia Lepore, Tiziana Notarangelo, Alessandro Sgambato, Franca Esposito, Francesca Maddalena & Matteo Landriscina. (2019) Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression. Cells 8:8, pages 798.
Crossref
Crossref
Abhijeet Deshmukh, Frank Arfuso, Philip Newsholme & Arun Dharmarajan. (2019) Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells. The International Journal of Biochemistry & Cell Biology 109, pages 23-32.
Crossref
Crossref
Hua Liang, Qiong Huang, Mei-juan Liao, Feng Xu, Tao Zhang, Jian He, Lei Zhang & Hong-zhen Liu. (2019) EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling. Inflammation Research 68:4, pages 325-336.
Crossref
Crossref
Evelyne Lima-Fernandes, Alex Murison, Tiago da Silva Medina, Yadong Wang, Anqi Ma, Cherry Leung, Genna M. Luciani, Jennifer Haynes, Aaron Pollett, Constanze Zeller, Shili Duan, Antonija Kreso, Dalia Barsyte-Lovejoy, Bradly G. Wouters, Jian Jin, Daniel D. De Carvalho, Mathieu Lupien, Cheryl H. Arrowsmith & Catherine A. O’Brien. (2019) Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells. Nature Communications 10:1.
Crossref
Crossref
Hideyuki Takeshima, Harumi Yamada & Toshikazu Ushijima. 2019. Oncogenomics. Oncogenomics
65
76
.
Vera Miranda-Gonçalves, Ana Lameirinhas, Rui Henrique & Carmen Jerónimo. (2018) Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets. Frontiers in Genetics 9.
Crossref
Crossref
Gurpreet Kaur, Praveen Sharma, Nilambra Dogra & Sandeep Singh. (2018) Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges. Current Treatment Options in Oncology 19:4.
Crossref
Crossref
Suraj Peri, Andrew J. Andrews, Aarti Bhatia & Ranee Mehra. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
327
352
.
Fuminori Ito, Yuki Yamada, Aiko Shigemitsu, Mika Akinishi, Hiroko Kaniwa, Ryuta Miyake, Shoichiro Yamanaka & Hiroshi Kobayashi. (2017) Role of Oxidative Stress in Epigenetic Modification in Endometriosis. Reproductive Sciences 24:11, pages 1493-1502.
Crossref
Crossref
Evelina Miele, Sergio Valente, Vincenzo Alfano, Marianna Silvano, Paolo Mellini, Diana Borovika, Biagina Marrocco, Agnese Po, Zein Mersini Besharat, Giuseppina Catanzaro, Giuseppe Battaglia, Luana Abballe, Clemens Zwergel, Giulia Stazi, Ciro Milite, Sabrina Castellano, Marco Tafani, Peteris Trapencieris, Antonello Mai & Elisabetta Ferretti. (2017) The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells. Oncotarget 8:40, pages 68557-68570.
Crossref
Crossref
Rogerio Castilho, Cristiane Squarize & Luciana Almeida. (2017) Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy. International Journal of Molecular Sciences 18:7, pages 1506.
Crossref
Crossref
Abhijeet Deshmukh, Mudra Binju, Frank Arfuso, Philip Newsholme & Arun Dharmarajan. (2017) Role of epigenetic modulation in cancer stem cell fate. The International Journal of Biochemistry & Cell Biology.
Crossref
Crossref
C C Wong, Y Qian & J Yu. (2017) Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches. Oncogene 36:24, pages 3359-3374.
Crossref
Crossref
Myriam Koubi, Christian Chabannon & Estelle Duprez. (2017) Au cœur d’une complexité biologique. médecine/sciences 33:5, pages 499-505.
Crossref
Crossref
Raushan T. Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev, Katherine Cosmopoulos, Heike Keilhack, Christine R. Klaus, Peter J. Houghton & Malcolm A. Smith. (2017) Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. Pediatric Blood & Cancer 64:3, pages e26218.
Crossref
Crossref
Richard L. Momparler, Sylvie Côté, Louise F. Momparler & Youssef Idaghdour. (2017) Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells. Frontiers in Oncology 7.
Crossref
Crossref
Omar Castillo-Aguilera, Patrick Depreux, Ludovic Halby, Paola Arimondo & Laurence Goossens. (2017) DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge. Biomolecules 7:4, pages 3.
Crossref
Crossref
Warren W. Burggren. 2017. Insect Epigenetics. Insect Epigenetics
1
30
.
Vahid Ezzatizadeh. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy
757
787
.
Pan Yu, Yawen Guo, Maimaiti Yusufu, Zeming Liu, Shan Wang, Xingjie Yin, Gongling Peng, Longqiang Wang, Xiangwang Zhao, Hui Guo, Tao Huang & Chunping Liu. (2016) Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells. Cell Biology International 40:10, pages 1062-1070.
Crossref
Crossref
R. Navakauskienė, M. Mori, M. S. Christodoulou, A. Zentelytė, B. Botta, L. Dalla Via, F. Ricci, G. Damia, D. Passarella, C. Zilio & N. Martinet. (2016)
Histone demethylating agents as potential
S
-adenosyl-
l
-methionine-competitors
. MedChemComm 7:6, pages 1245-1255.
Crossref
Crossref